Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
In Situ Hybridization, Fluorescence | 41 | 2020 | 2509 | 1.300 |
Why?
|
Chromosome Aberrations | 15 | 2022 | 1771 | 1.020 |
Why?
|
Comparative Genomic Hybridization | 14 | 2017 | 473 | 0.790 |
Why?
|
DNA Copy Number Variations | 11 | 2020 | 2017 | 0.730 |
Why?
|
Cytogenetic Analysis | 5 | 2016 | 270 | 0.710 |
Why?
|
Brain Neoplasms | 23 | 2021 | 9003 | 0.670 |
Why?
|
Chromosome Banding | 6 | 2016 | 260 | 0.590 |
Why?
|
Meningioma | 7 | 2024 | 1218 | 0.570 |
Why?
|
Meningeal Neoplasms | 7 | 2024 | 1248 | 0.560 |
Why?
|
Leiomyoma | 8 | 2003 | 636 | 0.560 |
Why?
|
Central Nervous System Neoplasms | 3 | 2020 | 916 | 0.540 |
Why?
|
Glioma | 13 | 2023 | 3434 | 0.520 |
Why?
|
Chromosome Deletion | 9 | 2015 | 1387 | 0.520 |
Why?
|
Abnormalities, Multiple | 6 | 2011 | 1422 | 0.520 |
Why?
|
Glioblastoma | 12 | 2023 | 3481 | 0.500 |
Why?
|
Hodgkin Disease | 6 | 2019 | 1378 | 0.480 |
Why?
|
Uterine Neoplasms | 8 | 2003 | 1420 | 0.420 |
Why?
|
Chromosomes, Human, Pair 9 | 5 | 2019 | 535 | 0.420 |
Why?
|
Translocation, Genetic | 7 | 2015 | 1388 | 0.420 |
Why?
|
Optic Nerve Glioma | 3 | 2021 | 32 | 0.410 |
Why?
|
Lipoma | 4 | 2017 | 292 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 12 | 2020 | 3631 | 0.400 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2024 | 478 | 0.390 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.390 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2021 | 1605 | 0.390 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2014 | 385 | 0.390 |
Why?
|
Chromosome Disorders | 2 | 2011 | 499 | 0.380 |
Why?
|
Cytogenetics | 2 | 2016 | 198 | 0.380 |
Why?
|
Genomics | 7 | 2021 | 5806 | 0.360 |
Why?
|
Gene Amplification | 7 | 2020 | 1086 | 0.340 |
Why?
|
Astrocytoma | 5 | 2014 | 775 | 0.330 |
Why?
|
Karyotyping | 9 | 2022 | 1171 | 0.320 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 2004 | 430 | 0.320 |
Why?
|
Prenatal Diagnosis | 2 | 2016 | 1265 | 0.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2016 | 8519 | 0.310 |
Why?
|
Medical Oncology | 1 | 2020 | 2318 | 0.300 |
Why?
|
HMGA2 Protein | 3 | 2004 | 102 | 0.300 |
Why?
|
Crying | 1 | 2007 | 37 | 0.290 |
Why?
|
Synaptotagmins | 1 | 2007 | 53 | 0.280 |
Why?
|
Gene Dosage | 9 | 2020 | 1218 | 0.280 |
Why?
|
Fallopian Tube Neoplasms | 2 | 2024 | 328 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2022 | 9267 | 0.280 |
Why?
|
Chromosomes, Human, Pair 10 | 5 | 2001 | 277 | 0.270 |
Why?
|
Isochromosomes | 1 | 2005 | 16 | 0.260 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2011 | 594 | 0.250 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2005 | 127 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.250 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2014 | 637 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2021 | 1405 | 0.230 |
Why?
|
Morpholines | 2 | 2019 | 580 | 0.230 |
Why?
|
Cerebellar Neoplasms | 2 | 2010 | 586 | 0.230 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2019 | 2052 | 0.220 |
Why?
|
Polyploidy | 1 | 2024 | 119 | 0.220 |
Why?
|
Aminopyridines | 2 | 2019 | 570 | 0.220 |
Why?
|
Mutation | 23 | 2022 | 30025 | 0.220 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3610 | 0.210 |
Why?
|
Genetic Testing | 2 | 2014 | 3535 | 0.200 |
Why?
|
Gene Deletion | 5 | 2002 | 2667 | 0.190 |
Why?
|
Gene Fusion | 2 | 2016 | 354 | 0.190 |
Why?
|
Lymphoma, B-Cell | 2 | 2019 | 940 | 0.190 |
Why?
|
Genes, Tumor Suppressor | 4 | 1998 | 1062 | 0.180 |
Why?
|
Humans | 115 | 2024 | 760437 | 0.180 |
Why?
|
Histiocytes | 1 | 2021 | 98 | 0.180 |
Why?
|
Neurofibromatosis 1 | 3 | 2021 | 560 | 0.180 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2553 | 0.180 |
Why?
|
Immunohistochemistry | 17 | 2020 | 11070 | 0.180 |
Why?
|
Oligodendroglioma | 2 | 2014 | 279 | 0.180 |
Why?
|
Genetic Diseases, Inborn | 2 | 2004 | 605 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2015 | 2821 | 0.180 |
Why?
|
Antibodies, Monoclonal | 4 | 2020 | 9176 | 0.170 |
Why?
|
Phenotype | 9 | 2020 | 16585 | 0.170 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1998 | 410 | 0.170 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1154 | 0.170 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.170 |
Why?
|
Abortion, Spontaneous | 2 | 2022 | 533 | 0.170 |
Why?
|
DNA Mutational Analysis | 8 | 2016 | 4108 | 0.170 |
Why?
|
Ovarian Neoplasms | 4 | 2024 | 4879 | 0.160 |
Why?
|
beta 2-Microglobulin | 2 | 2018 | 329 | 0.160 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 402 | 0.160 |
Why?
|
Oncogene Proteins | 3 | 2013 | 718 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2020 | 152 | 0.160 |
Why?
|
Genetics, Medical | 1 | 2021 | 336 | 0.160 |
Why?
|
Chromosome Breakage | 3 | 2008 | 159 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2024 | 523 | 0.160 |
Why?
|
Repressor Proteins | 3 | 2020 | 2978 | 0.160 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2020 | 194 | 0.150 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 253 | 0.150 |
Why?
|
Prognosis | 13 | 2022 | 29551 | 0.150 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 1998 | 29 | 0.150 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 126 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 370 | 0.150 |
Why?
|
Female | 64 | 2024 | 391875 | 0.150 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11096 | 0.150 |
Why?
|
Benzimidazoles | 2 | 2021 | 855 | 0.150 |
Why?
|
Blotting, Northern | 4 | 2010 | 1545 | 0.150 |
Why?
|
Peritoneal Neoplasms | 1 | 2024 | 711 | 0.150 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 98 | 0.140 |
Why?
|
Myelodysplastic Syndromes | 2 | 2005 | 1393 | 0.140 |
Why?
|
Chromosomes, Human, Pair 6 | 6 | 2013 | 373 | 0.140 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2000 | 267 | 0.140 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13616 | 0.140 |
Why?
|
NF-kappa B | 2 | 2019 | 2485 | 0.140 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 1998 | 166 | 0.140 |
Why?
|
Genome, Human | 6 | 2020 | 4423 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1445 | 0.130 |
Why?
|
Male | 56 | 2021 | 360035 | 0.130 |
Why?
|
Fallopian Tubes | 2 | 2013 | 177 | 0.130 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.130 |
Why?
|
Ependymoma | 1 | 2019 | 320 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Imidazolines | 1 | 2015 | 18 | 0.130 |
Why?
|
Chromosomes, Human, Pair 7 | 5 | 2008 | 310 | 0.130 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2007 | 321 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2022 | 978 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 193 | 0.130 |
Why?
|
Retinoblastoma | 1 | 2018 | 317 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4509 | 0.130 |
Why?
|
Developmental Disabilities | 3 | 2008 | 1508 | 0.130 |
Why?
|
Pinealoma | 1 | 2015 | 51 | 0.120 |
Why?
|
Sequence Analysis, DNA | 8 | 2020 | 4735 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 210 | 0.120 |
Why?
|
Heterozygote | 2 | 2008 | 2798 | 0.120 |
Why?
|
Glycoproteins | 1 | 2002 | 2207 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2015 | 2911 | 0.120 |
Why?
|
Proteins | 3 | 2019 | 6033 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 442 | 0.120 |
Why?
|
Carcinoma | 2 | 2020 | 2328 | 0.120 |
Why?
|
Gene Expression Profiling | 9 | 2016 | 9410 | 0.120 |
Why?
|
Optic Nerve Neoplasms | 1 | 2014 | 45 | 0.120 |
Why?
|
Medulloblastoma | 2 | 2010 | 678 | 0.120 |
Why?
|
Liposarcoma | 1 | 2017 | 285 | 0.110 |
Why?
|
Transcription Factors | 4 | 2018 | 12121 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4020 | 0.110 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2014 | 43 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 4 | 2017 | 2803 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 455 | 0.110 |
Why?
|
Lymphoma, T-Cell | 1 | 2016 | 304 | 0.110 |
Why?
|
Activin Receptors, Type I | 1 | 2014 | 134 | 0.110 |
Why?
|
Blotting, Southern | 3 | 2007 | 780 | 0.110 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 263 | 0.110 |
Why?
|
Cyclin E | 1 | 2013 | 156 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1624 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 367 | 0.110 |
Why?
|
Bone Marrow | 1 | 2023 | 2907 | 0.110 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 491 | 0.110 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6894 | 0.110 |
Why?
|
Trans-Activators | 2 | 2013 | 2858 | 0.110 |
Why?
|
Genes, Duplicate | 1 | 2012 | 30 | 0.100 |
Why?
|
Middle Aged | 35 | 2024 | 220382 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4567 | 0.100 |
Why?
|
Child | 21 | 2021 | 80086 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5292 | 0.100 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 1119 | 0.100 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2011 | 37 | 0.100 |
Why?
|
Immunoconjugates | 2 | 2016 | 953 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2018 | 2413 | 0.090 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
Adult | 32 | 2024 | 220781 | 0.090 |
Why?
|
Gene Expression | 3 | 2016 | 7582 | 0.090 |
Why?
|
Child, Preschool | 13 | 2020 | 42209 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1365 | 0.090 |
Why?
|
Chromosome Duplication | 1 | 2011 | 75 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 8 | 2016 | 17854 | 0.090 |
Why?
|
Gene Rearrangement | 5 | 2016 | 1125 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 850 | 0.090 |
Why?
|
Young Adult | 17 | 2020 | 59068 | 0.090 |
Why?
|
Immunomagnetic Separation | 1 | 2010 | 79 | 0.090 |
Why?
|
Elafin | 1 | 2010 | 31 | 0.090 |
Why?
|
Neuroblastoma | 1 | 2018 | 1250 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2016 | 1355 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 312 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3873 | 0.090 |
Why?
|
Aged | 24 | 2024 | 168840 | 0.090 |
Why?
|
Telomerase | 1 | 2015 | 745 | 0.090 |
Why?
|
Genes, erbB-2 | 1 | 2010 | 162 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1264 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 5 | 2015 | 1114 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 799 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5662 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.080 |
Why?
|
High Mobility Group Proteins | 2 | 2000 | 177 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2010 | 77 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1485 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 164 | 0.080 |
Why?
|
Tissue Array Analysis | 4 | 2013 | 550 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2009 | 349 | 0.080 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6330 | 0.080 |
Why?
|
Nervous System Neoplasms | 1 | 2008 | 91 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 2007 | 313 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1324 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2024 | 58859 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4240 | 0.070 |
Why?
|
Cell Lineage | 2 | 2014 | 2539 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2821 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4903 | 0.070 |
Why?
|
Tumor Cells, Cultured | 8 | 2013 | 6128 | 0.070 |
Why?
|
DNA Helicases | 2 | 2014 | 851 | 0.070 |
Why?
|
NFI Transcription Factors | 1 | 2007 | 42 | 0.070 |
Why?
|
Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8522 | 0.070 |
Why?
|
Glycolysis | 1 | 2011 | 832 | 0.070 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 48 | 0.070 |
Why?
|
Haploidy | 1 | 2007 | 133 | 0.070 |
Why?
|
Chromosome Mapping | 8 | 2008 | 4630 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2015 | 9598 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2012 | 1021 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
Human Development | 1 | 2008 | 123 | 0.070 |
Why?
|
Disease Progression | 6 | 2019 | 13484 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1897 | 0.070 |
Why?
|
Sirolimus | 2 | 2014 | 1533 | 0.070 |
Why?
|
Adolescent | 16 | 2020 | 88196 | 0.070 |
Why?
|
Apoptosis | 4 | 2016 | 9468 | 0.070 |
Why?
|
Reed-Sternberg Cells | 2 | 2018 | 72 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2860 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1997 | 786 | 0.070 |
Why?
|
Genetic Loci | 1 | 2015 | 2626 | 0.070 |
Why?
|
Pheochromocytoma | 1 | 2008 | 328 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12653 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1611 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2010 | 570 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2870 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 677 | 0.060 |
Why?
|
Aneuploidy | 1 | 2009 | 551 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10188 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 17639 | 0.060 |
Why?
|
Neoplasms | 6 | 2017 | 22083 | 0.060 |
Why?
|
Cell Line, Tumor | 7 | 2020 | 16945 | 0.060 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 1850 | 0.060 |
Why?
|
Congenital Abnormalities | 2 | 2008 | 706 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2007 | 244 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 653 | 0.060 |
Why?
|
Infant | 8 | 2020 | 36183 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3590 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2024 | 3777 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2015 | 929 | 0.060 |
Why?
|
Craniofacial Abnormalities | 1 | 2007 | 317 | 0.060 |
Why?
|
Urogenital Abnormalities | 1 | 2007 | 261 | 0.060 |
Why?
|
Seizures | 2 | 2007 | 2956 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2016 | 0.060 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 768 | 0.060 |
Why?
|
Tissue Distribution | 3 | 2014 | 2265 | 0.050 |
Why?
|
Genetic Markers | 3 | 2015 | 2612 | 0.050 |
Why?
|
Paraffin Embedding | 2 | 2017 | 302 | 0.050 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2010 | 940 | 0.050 |
Why?
|
Cohort Studies | 8 | 2022 | 41366 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2015 | 5794 | 0.050 |
Why?
|
beta Catenin | 1 | 2008 | 1040 | 0.050 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2001 | 287 | 0.050 |
Why?
|
Ki-67 Antigen | 2 | 2016 | 629 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15257 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5815 | 0.050 |
Why?
|
Base Sequence | 5 | 2014 | 12449 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2413 | 0.050 |
Why?
|
Formaldehyde | 2 | 2017 | 358 | 0.050 |
Why?
|
Myometrium | 1 | 2003 | 174 | 0.050 |
Why?
|
Oncogenes | 1 | 2008 | 1223 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2019 | 2113 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7380 | 0.050 |
Why?
|
Mice | 15 | 2023 | 81402 | 0.050 |
Why?
|
Signal Transduction | 5 | 2017 | 23397 | 0.050 |
Why?
|
Survival Rate | 5 | 2016 | 12698 | 0.050 |
Why?
|
Progestins | 1 | 2024 | 301 | 0.050 |
Why?
|
Atrophy | 1 | 2007 | 1631 | 0.050 |
Why?
|
Animals | 18 | 2023 | 168253 | 0.050 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2001 | 12 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5663 | 0.050 |
Why?
|
Brain | 2 | 2007 | 27060 | 0.050 |
Why?
|
Remission Induction | 2 | 2019 | 2394 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6570 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2018 | 1254 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 23953 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 2 | 1998 | 115 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5866 | 0.050 |
Why?
|
Scoliosis | 1 | 2008 | 740 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2204 | 0.050 |
Why?
|
Hybrid Cells | 2 | 1998 | 422 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7996 | 0.050 |
Why?
|
Blotting, Western | 3 | 2010 | 5031 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2001 | 192 | 0.050 |
Why?
|
Syndrome | 3 | 2007 | 3267 | 0.050 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 785 | 0.040 |
Why?
|
Mice, Nude | 4 | 2013 | 3603 | 0.040 |
Why?
|
Family Health | 2 | 2008 | 1257 | 0.040 |
Why?
|
Growth Disorders | 1 | 2004 | 653 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 580 | 0.040 |
Why?
|
Scalp | 1 | 2022 | 389 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 80430 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2022 | 748 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2014 | 0.040 |
Why?
|
South America | 1 | 2019 | 179 | 0.040 |
Why?
|
Cell Proliferation | 5 | 2016 | 10425 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4342 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2019 | 81 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2019 | 3592 | 0.040 |
Why?
|
Neurons | 2 | 2008 | 9443 | 0.040 |
Why?
|
Genotype | 4 | 2017 | 12976 | 0.040 |
Why?
|
Immunotherapy | 1 | 2014 | 4649 | 0.040 |
Why?
|
Dystrophin | 1 | 2000 | 283 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14661 | 0.040 |
Why?
|
Steroids | 1 | 2024 | 928 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2012 | 552 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3512 | 0.040 |
Why?
|
Face | 1 | 2004 | 1020 | 0.040 |
Why?
|
Multigene Family | 2 | 2013 | 1077 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11095 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5143 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2003 | 1992 | 0.040 |
Why?
|
Mice, SCID | 2 | 2016 | 2625 | 0.040 |
Why?
|
Certification | 1 | 2021 | 418 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 828 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 614 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 877 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3796 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3486 | 0.040 |
Why?
|
Algorithms | 2 | 2015 | 14002 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2805 | 0.040 |
Why?
|
Immunoblotting | 1 | 2020 | 1647 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 1058 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1997 | 375 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11729 | 0.030 |
Why?
|
Mechlorethamine | 1 | 2016 | 129 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2002 | 12785 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 85 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20985 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1233 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1315 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2297 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 2468 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2331 | 0.030 |
Why?
|
Pregnancy | 2 | 2022 | 29831 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 39947 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 1998 | 694 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3522 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39078 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 590 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1997 | 412 | 0.030 |
Why?
|
Bleomycin | 1 | 2016 | 494 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1997 | 457 | 0.030 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 332 | 0.030 |
Why?
|
Vinblastine | 1 | 2016 | 488 | 0.030 |
Why?
|
Educational Measurement | 1 | 2021 | 1250 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 634 | 0.030 |
Why?
|
Mycosis Fungoides | 1 | 2016 | 170 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 598 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6813 | 0.030 |
Why?
|
Pineal Gland | 1 | 2015 | 157 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.030 |
Why?
|
Human Genome Project | 2 | 2008 | 200 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2014 | 188 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 729 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4780 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 1997 | 516 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 249 | 0.030 |
Why?
|
Vincristine | 1 | 2016 | 1036 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12969 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2014 | 206 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3637 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3115 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8311 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 390 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3419 | 0.030 |
Why?
|
RNA, Neoplasm | 2 | 2010 | 749 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2642 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4319 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2016 | 625 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 709 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 659 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2895 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5296 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 897 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1084 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 316 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 1998 | 13445 | 0.020 |
Why?
|
Prednisone | 1 | 2016 | 1564 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2018 | 64591 | 0.020 |
Why?
|
Survival Analysis | 2 | 2017 | 10075 | 0.020 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 190 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6086 | 0.020 |
Why?
|
RNA Interference | 2 | 2010 | 2832 | 0.020 |
Why?
|
Eye Proteins | 1 | 2014 | 633 | 0.020 |
Why?
|
Down-Regulation | 1 | 1997 | 2911 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20078 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15867 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2215 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 696 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2326 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2008 | 48 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 841 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2392 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 319 | 0.020 |
Why?
|
Hirsutism | 1 | 2008 | 68 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1997 | 4808 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 934 | 0.020 |
Why?
|
Cell Line | 3 | 2008 | 15598 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2711 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36362 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2010 | 439 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1246 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1371 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2008 | 751 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2444 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 132 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 855 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2008 | 13312 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2453 | 0.020 |
Why?
|
Cell Survival | 2 | 2010 | 5790 | 0.020 |
Why?
|
Tretinoin | 1 | 1990 | 519 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2044 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2008 | 1306 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.020 |
Why?
|
Transfection | 2 | 2009 | 5776 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3609 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2008 | 321 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1598 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6297 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.020 |
Why?
|
Clinical Competence | 1 | 2021 | 4777 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1737 | 0.020 |
Why?
|
United States | 3 | 2021 | 72202 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1824 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1704 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5491 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2007 | 242 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2906 | 0.020 |
Why?
|
Protein Kinase C | 1 | 1990 | 1202 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1751 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3446 | 0.010 |
Why?
|
Ureter | 1 | 2007 | 367 | 0.010 |
Why?
|
Pneumonia | 1 | 2016 | 2140 | 0.010 |
Why?
|
Myocardium | 1 | 1997 | 4700 | 0.010 |
Why?
|
Hepatitis B, Chronic | 1 | 2008 | 410 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2820 | 0.010 |
Why?
|
Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5778 | 0.010 |
Why?
|
Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1998 | 2749 | 0.010 |
Why?
|
Pseudogenes | 1 | 2003 | 103 | 0.010 |
Why?
|
Euchromatin | 1 | 2003 | 54 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1404 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6471 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4936 | 0.010 |
Why?
|
Culture Techniques | 1 | 2003 | 531 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2007 | 718 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22097 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1135 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
Limb Deformities, Congenital | 1 | 2003 | 136 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8611 | 0.010 |
Why?
|
Gene Duplication | 1 | 2003 | 314 | 0.010 |
Why?
|
Retroelements | 1 | 2003 | 163 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6908 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4010 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3661 | 0.010 |
Why?
|
Transplantation, Heterologous | 2 | 1995 | 2385 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 2001 | 95 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6168 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1674 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 2003 | 330 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2007 | 1341 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.010 |
Why?
|
Williams Syndrome | 1 | 2003 | 193 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 1248 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74055 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1990 | 2423 | 0.010 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 2000 | 77 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 2464 | 0.010 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 1032 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3428 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 54339 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4383 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12429 | 0.010 |
Why?
|
Origin Recognition Complex | 1 | 1998 | 20 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1817 | 0.010 |
Why?
|
Replication Origin | 1 | 1998 | 77 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5865 | 0.010 |
Why?
|
CpG Islands | 1 | 2003 | 1225 | 0.010 |
Why?
|
Lung | 1 | 1997 | 9973 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1998 | 532 | 0.010 |
Why?
|
Fibroblasts | 1 | 2007 | 4106 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1738 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1997 | 700 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26280 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7597 | 0.010 |
Why?
|
Autistic Disorder | 1 | 2003 | 1219 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1998 | 1091 | 0.010 |
Why?
|
RNA | 1 | 2003 | 2721 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4174 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7046 | 0.010 |
Why?
|
DNA Replication | 1 | 1998 | 1418 | 0.010 |
Why?
|
Electroencephalography | 1 | 2007 | 6215 | 0.010 |
Why?
|
Computational Biology | 1 | 2003 | 3510 | 0.010 |
Why?
|
Cell Cycle | 1 | 1998 | 2929 | 0.010 |
Why?
|
Glycoconjugates | 1 | 1990 | 88 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22121 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 818 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18216 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20551 | 0.000 |
Why?
|
Drug Synergism | 1 | 1990 | 1755 | 0.000 |
Why?
|
DNA | 1 | 1997 | 7208 | 0.000 |
Why?
|
Age Factors | 1 | 1999 | 18379 | 0.000 |
Why?
|
Cell Division | 1 | 1990 | 4461 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18955 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10759 | 0.000 |
Why?
|